Conversely, overexpressing RANK enhances mammary tumor formation in the presence of progesterone [11] while in vivo administration of a synthetic progesterone upregulates RANKL levels in mammary epithelial cells [10]. This evidence concerns the gene TNFRSF11A and breast cancer.